14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $65.50 $80.00 Thursday, 25th Apr 2024 AXSM stock ended at $71.52. This is 0.492% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 4.23% from a day low at $69.53 to a day high of $72.47.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Oct 30, 2020 $67.21 $68.19 $65.32 $66.31 343 928
Oct 29, 2020 $66.61 $68.58 $65.80 $68.03 236 966
Oct 28, 2020 $67.00 $67.65 $65.70 $67.10 292 609
Oct 27, 2020 $68.69 $69.36 $67.51 $68.07 204 996
Oct 26, 2020 $71.00 $71.63 $67.95 $68.69 237 877
Oct 23, 2020 $70.61 $71.94 $69.84 $71.38 232 398
Oct 22, 2020 $69.07 $70.99 $68.58 $70.70 240 449
Oct 21, 2020 $70.24 $71.50 $68.20 $68.95 302 328
Oct 20, 2020 $72.42 $72.99 $69.99 $70.57 263 465
Oct 19, 2020 $74.47 $75.43 $71.79 $72.05 298 998
Oct 16, 2020 $74.44 $75.80 $73.30 $73.74 305 994
Oct 15, 2020 $73.60 $74.44 $72.66 $74.26 162 028
Oct 14, 2020 $75.48 $77.27 $74.49 $74.63 199 254
Oct 13, 2020 $73.54 $75.89 $72.90 $75.59 190 126
Oct 12, 2020 $75.50 $75.50 $73.12 $74.02 210 663
Oct 09, 2020 $74.18 $75.56 $73.22 $74.60 180 132
Oct 08, 2020 $73.81 $76.10 $72.85 $74.74 421 447
Oct 07, 2020 $74.24 $74.88 $72.42 $72.92 285 986
Oct 06, 2020 $74.35 $75.57 $73.08 $73.29 416 227
Oct 05, 2020 $71.24 $74.42 $71.24 $74.12 243 498
Oct 02, 2020 $70.55 $72.43 $70.18 $70.50 230 766
Oct 01, 2020 $71.65 $73.06 $70.25 $72.21 299 852
Sep 30, 2020 $71.75 $73.64 $69.41 $71.25 509 083
Sep 29, 2020 $72.07 $74.00 $70.00 $72.28 828 523
Sep 28, 2020 $77.37 $77.99 $75.79 $76.46 227 752
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT